Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care. Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only. Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order. If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. Learn more at www.genomind.com.
View Top Employees from GenomindWebsite | http://www.genomind.com |
Revenue | $16 million |
Funding | $66.8 million |
Employees | 80 (80 on RocketReach) |
Founded | 2009 |
Address | 2200 Renaissance Blvd, King of Prussia, Pennsylvania 19406, US |
Phone | (877) 895-8658 |
Technologies |
JavaScript,
HTML,
Twitter
+39 more
(view full list)
|
Industry | Hospitals and Health Care, Medical Testing & Clinical Laboratories, Other Devices and Supplies, Healthcare, Diagnostic Equipment |
Web Rank | 542850 |
Web Visits | 86450 |
Keywords | Genomind, Kombucha Benefits, Tests For Alzheimer's, Why Drink Kombucha, Link Between Food And The Brain, Benefits Of Kombucha |
Competitors | Admera Health, Assurex Health, Genelex, OneOme, Response Genetics |
SIC | SIC Code 807 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 541 Companies, NAICS Code 62 Companies, NAICS Code 621 Companies, NAICS Code 54 Companies |
Looking for a particular Genomind employee's phone or email?
The Genomind annual revenue was $16 million in 2024.
Dana Schorer is the Vice President Of Global Business Development of Genomind.
80 people are employed at Genomind.
Genomind is based in King of Prussia, Pennsylvania.
The NAICS codes for Genomind are [62151, 6215, 541, 62, 621, 54].
The SIC codes for Genomind are [807, 80].